Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05957562
Other study ID # AlAzharEArepairAzygouspreserve
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 10, 2020
Est. completion date April 9, 2023

Study information

Verified date July 2023
Source Al-Azhar University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Azygos vein preservation revisited: impact on early outcomes after repair of Esophageal atresia/ Tracheo-Esophageal Fistula in newborns. A randomized controlled study.


Description:

Since the first successful repair of esophageal atresia/tracheoesophageal fistula was performed approximately eight decades ago, surgeons have made considerable technical advances in solving intraoperative surgical challenges and reducing postoperative complications. According to some surgeons, the advantage of maintaining the Azygos vein makes this modification attractive. This study aimed to explore the benefits of retaining the Azygos vein during surgery for Esophageal Atresia with tracheoesophageal fistula, to emphasize its advantages in terms of reducing anastomotic leak, stricture, and other postoperative outcomes. Patients and Methods: This prospective randomized study was conducted between April 2020 and April 2023. The study included all newborns with (EA & TEF) eligible for primary repair, patients were randomly assigned to either Group A or Group B. (Group A) patients who underwent Azygos vein preservation during TEF repair, whereas the remaining patients (Group B) had Azygos vein disconnection. Statistical analysis: The Statistical Package for Social Sciences (SPSS) (version 23.0, IBM Corp IBM Corp., Armonk, NY, USA) was used for statistical analysis. The chi-square test (X2) was used to compare qualitative data in the groups, while an independent-sample t-test was used to compare quantitative data between groups. The degree of confidence was set at 95%. The p-value was considered significant at a level of 0.05. Discussion: will focus on advantages of azygous vein preservation on intactness of esophageal anastomosis, retaining the venous drainage of the bronchial system, and chest wall. Points of discussion will include effects of Azygous vein preservation on incidence of postoperative pneumonitis, anastomotic leakage and stricture rate, and mortality rate. The results obtained from this study will be compared between both groups and with those reported in the literature. Finally, the investigators will conclude the reconstructive technique that gives the better results and least morbidity.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date April 9, 2023
Est. primary completion date October 6, 2022
Accepts healthy volunteers No
Gender All
Age group 1 Day to 28 Days
Eligibility Inclusion Criteria: - all neonates suitable for primary repair of Esophageal Atresia and tracheoesophageal fistula Exclusion Criteria: - long gap esophageal atresia (> 3 cm) - esophageal atresia without tracheoesophageal fistula

Study Design


Intervention

Procedure:
EA/TOF primary repair with Azygos vein preservation
primary repair of EA/TOF with either azygous vein preservation or disconnection (to assess the effects and expected benefits of the former technique on viability of the repair and decrease of postoperative early complications and mortality rate)
EA/TOF primary repair with Azygos vein sacrifice (disconnection)
primary repair of EA/TOF with either azygous vein preservation or disconnection (to assess the effects and expected benefits of the former technique on viability of the repair and decrease of postoperative early complications and mortality rate)

Locations

Country Name City State
Egypt Pediatric Surgery Department, Al-Azhar University Cairo

Sponsors (1)

Lead Sponsor Collaborator
dr. Muhammad Abdelhafez Mahmoud, MD

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other Spitz classification Spitz classification of mortality risk of TOF/EA in number 2 years
Primary gap between the pouches after mobilization missed distance between the mobilized esophageal pouches in centimeters 2 years
Primary operative time operative time in minutes 2 years
Primary early postoperative pneumonia postoperative pneumonitis in number 35 months
Primary early postoperative anastomotic leak anastomotic leakage rate in number 35 months
Primary early postoperative anastomotic stricture anastomotic stricture rate in number 35 months
Primary mortality mortality rate in number 35 months
Secondary gestational age gestational age in weeks 2 years
Secondary sex patient's gender in number 2 years
Secondary associated congenital anomalies associated congenital anomalies in number 2 years
Secondary associated anomalies associated congenital anomalies in percentage of cases 2 years
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05390684 - Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.
Enrolling by invitation NCT05725967 - Endoscopic Metabolic and Bariatric Therapies
Completed NCT05987787 - Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy
Completed NCT05753709 - Conventional Hand Sewn End-To-End Anastomosis Versus Side-To-Side Anastomosis for Stoma Reversal: A Prospective Study N/A
Completed NCT05476159 - Indocyanine Green Test in Bariatric Surgery
Recruiting NCT03148054 - Computed Tomography vs. Endoscopy Study
Recruiting NCT04162860 - Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy N/A